StockData
Cytokinetics Inc logo

Cytokinetics Inc (CYTK) stock

CYTKNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 4, 2026Score 4/30
$51.32−0.33 (-0.64%)

Close on Nov 18, 2026Market cap $7.13BP/E –Yield –

Cytokinetics shares outstanding

Diluted shares outstanding: the weighted share count used for earnings per share, adjusted for stock splits.

Cytokinetics's shares outstanding was 0M at Jun 30, 2026. For fiscal 2025 it was 0M, up 7.3% from the year before. Over ten years it grew -43.9% a year on average. The highest annual figure on record is 49M in fiscal 2017.

Annual shares outstanding

PeriodPeriod endValueChange
FY2025Dec 31, 20250M+7.3%
FY2024Dec 31, 20240M+16.0%
FY2023Dec 31, 20230M+7.5%
FY2022Dec 31, 20220M+16.8%
FY2021Dec 31, 20210M+19.2%
FY2020Dec 31, 20200M+12.1%
FY2019Dec 31, 20190M+5.8%
FY2018Dec 31, 20180M-99.9%
FY2017Dec 31, 201749M+16.1%
FY2016Dec 31, 201643M+9.7%
FY2015Dec 31, 201539M+8.7%
FY2014Dec 31, 201436M+30.9%
FY2013Dec 31, 201327M+50.6%
FY2012Dec 31, 201218M+53.4%
FY2011Dec 31, 201112M+10.3%
FY2010Dec 31, 201011M+10.7%
FY2009Dec 31, 200910M–

Quarterly shares outstanding

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 20260M+10.6%
Q1 FY2026Mar 31, 20260M+4.0%
Q4 FY2025Dec 31, 20250M+3.7%
Q3 FY2025Sep 30, 20250M+2.0%
Q2 FY2025Jun 30, 20250M+9.4%
Q1 FY2025Mar 31, 20250M+16.3%
Q4 FY2024Dec 31, 20240M+19.2%
Q3 FY2024Sep 30, 20240M+22.5%
Q2 FY2024Jun 30, 20240M+14.1%
Q1 FY2024Mar 31, 20240M+7.1%
Q4 FY2023Dec 31, 20230M+4.6%
Q3 FY2023Sep 30, 20230M+2.5%
Q2 FY2023Jun 30, 20230M+11.7%
Q1 FY2023Mar 31, 20230M+12.0%
Q4 FY2022Dec 31, 20220M+12.5%
Q3 FY2022Sep 30, 20220M+16.7%
Q2 FY2022Jun 30, 20220M+19.5%
Q1 FY2022Mar 31, 20220M+19.4%
Q4 FY2021Dec 31, 20210M+18.7%
Q3 FY2021Sep 30, 20210M+17.6%
Q2 FY2021Jun 30, 20210M+20.4%
Q1 FY2021Mar 31, 20210M+20.1%
Q4 FY2020Dec 31, 20200M+19.8%
Q3 FY2020Sep 30, 20200M+16.4%
Q2 FY2020Jun 30, 20200M+3.4%
Q1 FY2020Mar 31, 20200M+8.1%
Q4 FY2019Dec 31, 20190M-99.9%
Q3 FY2019Sep 30, 20190M-99.9%
Q2 FY2019Jun 30, 20190M-99.9%
Q1 FY2019Mar 31, 20190M-99.9%
Q3 FY2018Sep 30, 201855M+1.7%
Q2 FY2018Jun 30, 201854M+12.6%
Q1 FY2018Mar 31, 201854M+30.0%
Q4 FY2017Dec 31, 201754M+24.1%
Q3 FY2017Sep 30, 201754M+24.3%
Q2 FY2017Jun 30, 201748M–
Q1 FY2017Mar 31, 201742M–
Q4 FY2016Dec 31, 201644M–
Q3 FY2016Sep 30, 201643M–

More Cytokinetics figures

See a number that looks wrong?